BOSTON SCIENTIFIC CORP (BSX) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:BSX - US1011371077 - Common Stock
97.52 USD
-0.2 (-0.2%)
97.72 USD
+0.2 (+0.21%)
ChartMill assigns a Buy % Consensus number of 86% to BSX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 128.25. This target is 31.51% above the current price.
BSX was analyzed by 40 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BSX.
In the previous month the buy percentage consensus was at a similar level.
BSX was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-23 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-22 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-17 | Needham | Reiterate | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-01 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-10-01 | BTIG | Maintains | Buy -> Buy |
| 2025-10-01 | Needham | Reiterate | Buy -> Buy |
| 2025-10-01 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-01 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-29 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-09-23 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-19 | Needham | Reiterate | Buy -> Buy |
| 2025-09-11 | Needham | Reiterate | Buy -> Buy |
| 2025-09-08 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-07-24 | UBS | Maintains | Buy -> Buy |
| 2025-07-24 | Oppenheimer | Maintains | Perform -> Perform |
| 2025-07-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-24 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-07-24 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-24 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-16 | Leerink Partners | Initiate | Outperform |
| 2025-05-28 | Needham | Reiterate | Buy -> Buy |
BOSTON SCIENTIFIC CORP / BSX FAQ
What is the average price target for BOSTON SCIENTIFIC CORP (BSX) stock?
40 analysts have analysed BSX and the average price target is 128.25 USD. This implies a price increase of 31.51% is expected in the next year compared to the current price of 97.52.
What is the consensus rating for BOSTON SCIENTIFIC CORP (BSX) stock?
The consensus rating for BOSTON SCIENTIFIC CORP (BSX) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.